Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Super Paramagnetic Iron Oxide (Magtrace) Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer - The MagBracket Study.

NCT07844473 is registered in ClinicalTrials.gov with King Faisal Specialist Hospital & Research Center as lead sponsor.

NCT NCT07844473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07844473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Super Paramagnetic Iron Oxide (Magtrace) Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer - The MagBracket Study.
Lead sponsor
King Faisal Specialist Hospital & Research Center
Phase
Not applicable
Overall status
Recruiting
Start date
July 24, 2026
Completion date
August 31, 2029
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer (triple negative breast cancer (tnbc)), breast cancer (triple negative type), breast cancer - ductal carcinoma in situ (dcis), breast cancer - infiltrating ductal carcinoma, breast cancer with low to intermediate her2 expression